Skip to main content

Table 3 Baseline characteristics of DM and NC groups

From: The impact of insulin pump therapy to oxidative stress in patients with diabetic nephropathy

 

Groups

T value/χ2

P

NC

DM

Gender (M/F)

31/49

35/45

0.413

0.630

Age (years)

53.1 ± 7.0

54.1 ± 7.4

− 0.845

0.4

BMI (kg/m2)

23.8 ± 1.3

24.7 ± 2.0

− 3.465

0.001*

SBP (mmHg)

127.1 ± 9.1

132.3 ± 12.1

− 3.097

0.002*

DBP (mmHg)

77.2 ± 6.2

77.4 ± 5.4

− 0.284

0.777

HBA1c (%)

5.2 ± 0.4

10.6 ± 1.5

− 30.098

0.000*

FPG (mmol/l)

4.6 ± 0.6

12.4 ± 1.8

− 38.143

0.000*

2hPG (mmol/l)

5.7 ± 0.4

16.5 ± 1.2

− 76.735

0.000*

HOMA-IR

1.4 ± 0.3

3.3 ± 0.5

− 26.932

0.000*

IL-6 (pg/l)

94.7 ± 11.2

167.90 ± 15.46

− 34.292

0.000*

TC (mmol/l)

4.0 ± 0.7

5.0 ± 1.0

− 7.198

0.0008*

TG (mmol/l)

1.5 ± 0.2

2.8 ± 0.9

− 13.499

0.000*

LDL (mmol/l)

2.5 ± 0.3

3.3 ± 0.8

− 8.112

0.000*

HDL (mmol/l)

1.4 ± 0.3

1.1 ± 0.4

6.121

0.000*

3-NT (nmol/l)

78.6 ± 7.4

121.5 ± 9.9

− 31.13

0.000*

SOD (U/ml)

124.8 ± 17.6

102.6 ± 20.5

7.332

0.000*

8-OHdG (ng/ml)

6.9 ± 3.8

25.4 ± 4.4

− 28.471

0.000*

GSH (mg/l)

152.5 ± 18.9

134.3 ± 15.3

6.663

0.000*

CRP (mg/l)

2.6 ± 0.7

8.46 ± 1.79

− 27.477

0.000*

  1. Chi square test, others were t test; * P < 0.05 compared with the normal control group